North America Primary Angle Closure Glaucoma Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) :
% 
 Período de pronóstico |
2021 –2028 |
 Tamaño del mercado (año base) |
USD 113.24 Million |
 Tamaño del mercado (año de pronóstico) |
USD 176.34 Million |
 Tasa de crecimiento anual compuesta (CAGR) |
% |
| Jugadoras de los principales mercados |
>Mercado de glaucoma de ángulo cerrado primario de América del Norte, por tipo de enfermedad (glaucoma de ángulo cerrado agudo y glaucoma de ángulo cerrado crónico), tipo (diagnóstico y tratamiento), usuario final (hospitales, centros quirúrgicos ambulatorios, clínicas especializadas y otros), canal de distribución (licitación directa, ventas minoristas y otros), país (EE. UU., Canadá, México), tendencias de la industria y pronóstico hasta 2028.
Análisis y perspectivas del mercado: mercado de glaucoma de ángulo cerrado primario en América del Norte
Se espera que el mercado de glaucoma de ángulo cerrado primario de América del Norte gane un crecimiento significativo en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 5,7% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 176,34 millones para 2028 desde USD 113,24 millones en 2020. La creciente prevalencia del glaucoma de ángulo cerrado y el aumento de la población geriátrica son los principales impulsores que se espera que impulsen el crecimiento del mercado en el período de pronóstico.
El glaucoma es un grupo de enfermedades oculares que dañan el nervio óptico, y el funcionamiento adecuado del nervio óptico es necesario para una buena visión. Este daño suele ser causado por una presión anormalmente alta en el ojo. El cierre angular primario (CAP) se define como el cierre aposicional del ángulo de la cámara anterior que puede provocar una obstrucción del flujo de salida del humor acuoso y un aumento de la presión intraocular, en ausencia de neuropatía óptica glaucomatosa. El CAP es generalmente bilateral; un mercado de glaucoma de ángulo cerrado primario incluye la técnica de detección del glaucoma de ángulo cerrado primario en una etapa temprana para llevar a cabo el futuro enfoque de tratamiento quirúrgico que puede reducir la tasa de ceguera asociada con el cierre angular primario. La naturaleza asintomática de la enfermedad en la etapa temprana hace que el diagnóstico incorrecto o inexacto del glaucoma de ángulo cerrado primario conduzca a un tratamiento incorrecto que causa una carga adicional en el bolsillo del paciente y causa una disminución en la confiabilidad del producto de diagnóstico.
La creciente prevalencia del glaucoma de ángulo cerrado y el aumento de la población geriátrica están impulsando el crecimiento del mercado de glaucoma de ángulo cerrado primario en América del Norte. Sin embargo, se espera que el alto costo quirúrgico del PACG y el escenario de reembolso inadecuado obstaculicen el crecimiento del mercado en el período previsto. Por otro lado, se prevé que la reciente aprobación de los organismos reguladores y el aumento de las iniciativas gubernamentales en relación con el glaucoma impulsen el crecimiento del mercado. La falta de profesionales capacitados y el acceso limitado al tratamiento pueden actuar como un desafío para el crecimiento del mercado.
The North America primary angle-closure glaucoma market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
North America Primary Angle-Closure Glaucoma Market Scope and Market Size
The North America primary angle-closure glaucoma market is segmented on the basis of disease type, type, end user, and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of disease type, the primary angle-closure glaucoma market is segmented into acute angle-closure glaucoma and chronic angle-closure glaucoma. In 2021, acute angle-closure glaucoma segment is expected to dominate in the primary angle-closure glaucoma market owing to the high incidence cases for acute cases. Acute attack of angle closure glaucoma is at high risk and the maximum number of cases which ophthalmologist diagnose are of acute angle closure glaucoma.
- On the basis of type, the primary angle-closure glaucoma market is segmented into diagnosis and treatment. In 2021, diagnosis segment is expected to dominate in the primary angle-closure glaucoma market due to the primary test and secondary testing options available for the diagnosis and physicians after a proper diagnosis only prefer the medical procedure. Treatment segment in this market is totally based on surgical intervention due to which the market share for treatment is less than diagnosis.
- On the basis of end user, the primary angle-closure glaucoma market is segmented into hospitals, specialty clinics, ambulatory surgical centres, and others. In 2021, hospital segment is expected to dominate the primary angle-closure glaucoma market this segment is specialized in conducting various surgical interventions and have a large professional’s portfolio available for giving the proper treatment. Moreover, cost-effective and high quality diagnostic care and services in safe healthcare environment and are convenient for consulting physician/healthcare institution to outsource bulk diagnostics tests to independent diagnostic laboratories for better customer services.
- On the basis of distribution channel, the primary angle-closure glaucoma market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is expected to dominate the primary angle-closure glaucoma market as they are the primary source of procurement of diagnostic and surgical devices by healthcare organizations and specialty clinics. With the increasing cost of healthcare, healthcare service providers are focusing on better services for customers along with reducing the overall cost. The procurement of products through direct tender is highly cost effective for healthcare providers.
North America Primary Angle-Closure Glaucoma Market Country Level Analysis
The North America primary angle-closure glaucoma market is analysed and market size information is provided product, disease type, type, end user, and distribution channel.
The countries covered in the North America primary angle-closure glaucoma market report are U.S., Canada, and Mexico.
- In 2021, U.S. is expected to dominate the market due to the presence of the largest consumer market with high GDP. Moreover, the U.S. has the largest research and development spending in the world and offers trade agreements with several countries making it the largest market for consumer primary angle closure glaucoma diagnosis and surgical products. Canada is expected to showcase substantial growth in the North America market due to increasing economic burden of the country. On the other hand, Mexico is expected to grow in the forecast period of 2021 to 2028 due to rising geriatric population in the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Geriatric Population and Growing Prevalence of Angle-Closure Glaucoma in the Region are Creating New Opportunities for Players in the North America Primary Angle-Closure Glaucoma Market
North America primary angle-closure glaucoma market also provides you with detailed market analysis for every country growth in particular industry with the primary angle-closure glaucoma market sales, impact of advancement in the primary angle-closure glaucoma market and changes in regulatory scenarios with their support for the primary angle-closure glaucoma market. The data is available for historic period 2010 to 2019.
Competitive Landscape and North America Primary Angle-Closure Glaucoma Market Share Analysis
El panorama competitivo del mercado de glaucoma de ángulo cerrado primario de América del Norte proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, los sitios e instalaciones de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, las líneas de prueba de productos, las aprobaciones de productos, las patentes, la amplitud y la extensión de los productos, el dominio de las aplicaciones y la curva de la línea de vida de la tecnología. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de la empresa relacionado con el mercado de glaucoma de ángulo cerrado primario.
Las principales empresas cubiertas en el informe son Johnson & Johnson Vision Care, Inc. (una subsidiaria de Johnson & Johnson Services Inc.), New World Medical, Inc., Sight Sciences, Inc., NIDEK CO., LTD, BVI, MicroSurgical Technology, Allergan (una subsidiaria de AbbVie Inc.), Bausch & Lomb Incorporated (una subsidiaria de Bausch Health Companies Inc.), Oertli Instrumente AG, NOVAEYE MEDICAL, ZEISS International, Alcon Inc., LIGHTMED, Luneau Technology USA, Reichert, Inc. (una unidad de negocios de Ametek Inc.) y NEW VISION, entre otras.
Varias empresas en todo el mundo también han iniciado lanzamientos de productos y acuerdos que también están acelerando el mercado primario del glaucoma de ángulo cerrado.
Por ejemplo,
- En octubre de 2019, MicroSurgical Technology anunció que había adquirido el sistema quirúrgico Trabectome y Goniotome de Neomedix Corporation. Trabectome se utiliza en tecnología quirúrgica importante para el glaucoma. Esta adquisición aumentó la cartera de productos de la empresa y, por lo tanto, mejoró sus ganancias.
- En octubre de 2018, Reichert, Inc. anunció la introducción de su nuevo tonómetro portátil Tono-Pen AVIA, ahora con modo de medición Quick-Tap. Quick-Tap es ideal para pacientes sensibles a la tonometría de aplanación o para pacientes posoperatorios. Este instrumento era fácil de usar debido al aumento de la demanda entre los pacientes.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET end user coverage GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Epidemiology
- Regulatory Framework
- Pipeline analysis
- market overview
- drivers
- INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA
- INCREASING WOMEN POPULATION
- RISE IN GERIATRIC POPULATION
- ADVANCEMENTS IN SURGICAL TREATMENT OF THE DISEASE
- INCREASED ECONOMIC BURDEN
- RESTRAINTS
- HIGH SURGICAL COSTS OF PACG
- INADEQUATE REIMBURSEMENT SCENARIO
- DELAYED AND MISDIAGNOSIS OF PACG
- OPPORTUNITIES
- INCREASING GOVERNMENT INITIATIVES TOWARDS GLAUCOMA
- RECENT APPROVAL BY GOVERNING BODIES
- RAPID TRANSITION FROM PACG MEDICATION TO SURGERIES
- CHALLENGES
- RISKS ASSOCIATED WITH SURGICAL PROCEDURES
- LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
- LIMITED ACCESS TO TREATMENT
- IMPACT OF COVID-19 ON North america PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISION BY MANUFACTURERS
- CONCLUSION
- NORTH AMERICA PRIMARY ANGLE CLOSURE GLAUCOMA Market, By DISEASE TYPE
- overview
- acute angle-closure glaucoma market
- chronic angle-closure glaucoma market
- North america primary angle-closure glaucoma MARKET, BY TYPE
- overview
- Diagnosis
- primary test
- GONIOSCOPY EXAMINATION
- SLIT-LAMP EXAMINATION
- AUTOMATIC STATIC PERIMETRY
- SECONDARY test
- ULTRASOUND BIOMICROSCOPY
- ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY (OCT)
- RETINAL OCT
- FUNDOSCOPY
- OTHERS
- Treatment
- Surgical Iridectomy
- TRABECULECTOMY
- Micro invasive glaucoma technique (MIGS)
- goniotomy
- Others
- North America primary angle-closure glaucoma MARKET, BY end user
- overview
- HoSpitals
- AMbulatory surgical Centers
- Specialty Clinics
- others
- North America Primary Angle-Closure Glaucoma MARKET, BY distribution channel
- overview
- direct tender
- retail sales
- Others
- North America primary angle-closure glaucoma MARKET, BY Country
- NORTH AMERICA
- U.S.
- CANADA
- MEXICO
- North America primary angle-closure glaucoma Market: COMPANY landscape
- company share analysis: North America
- SWOT
- company profiles
- johnson & johnson vision care, inc. (a subsidiary of johnson & johnson services, inc.)
- COMPANY SNAPSHot
- Revenue analysis
- product Portfolio
- RECENT DEVELOPMENTS
- bausch & lomb incorporated (a subsidiary of bausch health Companies Inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- alcon inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Zeiss International
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- NOVA EYE MEDICAL LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- NIDEK CO., LTD
- COMPANY SNAPShot
- product Portfolio
- RECENT DEVELOPMENTS
- allergan (a subsidiary of abbvie inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- BVI
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- LIGHTMED
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Luneau technology usa
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- microsurgical technology
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- new vision
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- New World Medical, Inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Oertli Instrumente AG
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Reichert, inc. (A business unit of ametek.inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Sight Sciences, inc.
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- questionnaire
- related reports
Lista de Tablas
TABLE 1 NORTH AMERICA Primary Angle-Closure Glaucoma Market, Pipeline Analysis
TABLE 2 NUMBER OF OPHTHALMOLOGISTS/MILLION POPULATIONS
TABLE 3 North america Primary angle closure glaucoma market, By disease type, 2019-2028 (USD million)
TABLE 4 North america Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 5 North America Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 6 North america Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 7 North america Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 8 North America Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 9 North America Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 10 North America Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 11 North America PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)
TABLE 12 U.S. PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 13 U.S. Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 14 U.S. Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 15 U.S. Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 16 U.S. Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 17 U.S. Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 18 U.S. Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 19 U.S. Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 20 CANADA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 21 CANADA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 22 CANADA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 23 CANADA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 24 CANADA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 25 CANADA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 26 CANADA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 27 CANADA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 28 MEXICO PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)
TABLE 29 MEXICO Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 30 MEXICO Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 31 MEXICO Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 32 MEXICO Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 33 MEXICO Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)
TABLE 34 MEXICO Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)
TABLE 35 MEXICO Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)
Lista de figuras
FIGURE 1 NORTH America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: segmentation
FIGURE 2 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET : data triangulation
FIGURE 3 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: North America VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: MULTIVARIATE MODELLING
FIGURE 7 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DBMR MARKET POSITION GRID
FIGURE 9 North America primary angle-closure glaucoma market: MARKET end user coverage GRID
FIGURE 10 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 North america primary angle-closure glaucoma market: SEGMENTATION
FIGURE 12 INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA and ADVANCEMENT IN SURGICAL TREATMENT OF THE DISEASE are DRIVing THE NORTH AMERICA primary angle-closure glaucoma market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 ACUTE ANGLE-CLOSURE GLAUCOMA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
FIGURE 15 North America Primary angle closure glaucoma market: By disease type, 2020
FIGURE 16 North america Primary angle closure glaucoma market: By disease type, 2020-2028 (USD Million)
FIGURE 17 North America Primary angle closure glaucoma market: By disease type, CAGR (2020-2028)
FIGURE 18 North america Primary angle closure glaucoma market: By disease type, LIFELINE CURVE
FIGURE 19 North america primary angle-closure glaucoma market: BY TYPE, 2020
FIGURE 20 North america primary angle-closure glaucoma market: BY TYPE 2020-2028 (USD Million)
FIGURE 21 North america primary angle-closure glaucoma market: BY TYPE, CAGR (2021-2028)
FIGURE 22 North america primary angle-closure glaucoma market: BY TYPE, LIFELINE CURVE
FIGURE 23 North America Primary Angle-Closure Glaucoma market: BY end user, 2020
FIGURE 24 North America Primary Angle-Closure Glaucoma market: BY end user, 2020-2028 (USD Million)
FIGURE 25 North America Primary Angle-Closure Glaucoma market: BY end user, CAGR (2021-2028)
FIGURE 26 North America Primary Angle-Closure Glaucoma market: BY end user, LIFELINE CURVE
FIGURE 27 North America Primary Angle-Closure Glaucoma market: BY distribution channel, 2020
FIGURE 28 North America Primary Angle-Closure Glaucoma market: BY distribution channel, 2020-2028 (USD Million)
FIGURE 29 North America Primary Angle-Closure Glaucoma market: BY distribution channel, CAGR (2021-2028)
FIGURE 30 North America Primary Angle-Closure Glaucoma market: BY distribution, LIFELINE CURVE
FIGURE 31 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)
FIGURE 32 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)
FIGURE 33 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)
FIGURE 34 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)
FIGURE 35 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)
FIGURE 36 north america primary angle-closure glaucoma market: company share 2020 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
